Advertisement

European Journal of Dermatology

, Volume 28, Issue 5, pp 649–653 | Cite as

High serum 25-hydroxyvitamin D concentration in patients with a recent diagnosis of non-melanoma skin cancer: a case-control study

  • Andressa M. Soares
  • Vera L. Szejnfeld
  • Mauro Y. Enokihara
  • Nílceo Michalany
  • Charlles HM CastroEmail author
Clinical report
  • 3 Downloads

Abstract

Background

Sun exposure is critical for vitamin D synthesis and is a major risk factor for the development of non-melanoma skin cancer (NMSC). NMSC is the most common type of cancer in Brazil and coexists with a very high prevalence of vitamin D deficiency.

Objectives

The present study aimed to assess serum 25-hydroxyvitamin D (25[OH]D) concentration in patients with a recent diagnosis of NMSC.

Materials & methods

The serum 25(OH)D concentration of patients with a histological diagnosis of NMSC, made between September 2016 and September 2017, was measured by chemiluminescence up to 60 days after diagnosis and compared to healthy individuals without NMSC matched by age, sex, BMI, and skin phototype.

Results

Forty-one patients with NMSC and 200 healthy controls were evaluated. Most of the patients were men (56.1%) and most had basal cell carcinoma (90.2%). Patients were 67 years old on average (21-87 years) with skin Phototype 2 or 3 (80.6%). Mean serum 25(OH)D concentration inNMSCpatientswas significantly higher than in healthy controls (p<0.001). Most of the patients with NMSC (65.9%) had vitamin D deficiency (25[OH]D <30 ng/mL). No association was identified between histological type, time from diagnosis, or a previous history of skin neoplasm and 25(OH)D measurements.

Conclusion

Patients with recently diagnosed NMSC had significantly higher serum levels of 25(OH)D when compared to healthy controls. On the other hand, most of the NMSC patients were still considered to have vitamin D insufficiency.

Key words

vitamin D sun exposure non-melanoma skin cancer basal cell carcinoma (BCC) squamous cell carcinoma (SCC) 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Guessous I. Role of vitamin D deficiency in extraskeletal complications: predictor of health outcome or marker of health status? BioMed Res Int 2015; 2015: 563403.CrossRefGoogle Scholar
  2. 2.
    Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol 2014; 2: 76–89.CrossRefGoogle Scholar
  3. 3.
    Mithal A, Wahl DA, Bonjour JP, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009; 20: 1807–20.CrossRefGoogle Scholar
  4. 4.
    Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 2017; 18: 153–65.CrossRefGoogle Scholar
  5. 5.
    Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006; 116: 2062–72.CrossRefGoogle Scholar
  6. 6.
    Vieth R. Vitamin D supplementation, 25–hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842–56.CrossRefGoogle Scholar
  7. 7.
    Pinheiro MM, Schuch NJ, Genaro PS, Ciconelli RM, Ferraz MB, Martini LA. Nutrient intakes related to osteoporotic fractures in men and women–the Brazilian Osteoporosis Study (BRAZOS). Nutr J 2009; 8: 6.CrossRefGoogle Scholar
  8. 8.
    Domiciano DS, Machado LG, Lopes JB, et al. Bone mineral density and parathyroid hormone as independent risk factors for mortality in community–dwelling older adults: a population–based prospective cohort study in Brazil. The Sao Paulo Ageing & Health (SPAH) Study. J Bone Miner Res 2016; 31: 1146–57.Google Scholar
  9. 9.
    Eloi M, Horvath DV, Szejnfeld VL, et al. Vitamin D deficiency and seasonal variation over the years in Sao Paulo, Brazil. Osteoporos Int 2016; 27: 3449–56.CrossRefGoogle Scholar
  10. 10.
    Lopes VM, Lopes JR, Brasileiro JP, et al. Highly prevalence of vitamin D deficiency among Brazilian women of reproductive age. Arch Endocrinol Metab 2017; 61: 21–7.CrossRefGoogle Scholar
  11. 11.
    Moreira ML, Neto LV, Madeira M, Lopes RF, Farias ML. Vitamin D deficiency and its influence on bone metabolism and density in a Brazilian population of healthy men. J Clin Densitom 2018; 21: 91–7.CrossRefGoogle Scholar
  12. 12.
    Holick MF. Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging 2007; 24: 1017–29.CrossRefGoogle Scholar
  13. 13.
    Holick MF. Evolution, biologic functions and recommended dietary allowance for vitamin D. In: Holick MF, editor. Vitamin D: physiology, molecular biology and clinical applications. Totowa, New Jersey: Humana Press, 1999, p. 1–16.Google Scholar
  14. 14.
    Bikle DD. Vitamin D metabolism and function in the skin. Mol cell Endocrinol 2011; 347: 80–9.CrossRefGoogle Scholar
  15. 15.
    Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266–81.CrossRefGoogle Scholar
  16. 16.
    Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006; 92: 4–8.CrossRefGoogle Scholar
  17. 17.
    Grigalavicius M, Moan J, Dahlback A, Juzeniene A. Daily, seasonal, and latitudinal variations in solar ultraviolet A and B radiation in relation to vitamin D production and risk for skin cancer. Int J Dermatol 2016; 55: e23–8.CrossRefGoogle Scholar
  18. 18.
    van der Pols JC, Russell A, Bauer U, Neale RE, Kimlin MG, Green AC. Vitamin D status and skin cancer risk independent of time outdoors: 11–year prospective study in an Australian community. J Invest Dermatol 2013; 133: 637–41.CrossRefGoogle Scholar
  19. 19.
    Krishnan AV, Feldman D. Mechanisms of the anti–cancer and anti–inflammatory actions of vitamin D. Ann Rev Pharmacol Toxicol 2011; 51: 311–36.CrossRefGoogle Scholar
  20. 20.
    Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Cancer Incidence in Brazil–Estimate 2016. CoordenaÇão de PrevenÇão e Vigilância. Brazil: INCA, 2015, http: //www. inca.gov.br/estimativa/2016/estimativa–2016–v11.pdf (Accessed 20th November 2017).Google Scholar
  21. 21.
    Maeda SS, Saraiva GL, Hayashi LF, et al. Seasonal variation in the serum 25–hydroxyvitamin D levels of young and elderly active and inactive adults in Sao Paulo, Brazil: The Sao PAulo Vitamin D Evaluation Study (SPADES). Dermatoendocrinol 2013; 5: 211–7.CrossRefGoogle Scholar
  22. 22.
    Saraiva GL, Cendoroglo MS, Ramos LR, et al. Prevalence of vitamin D deficiency, insufficiency and secondary hyperparathyroidism in the elderly inpatients and living in the community of the city of Sao Paulo, Brazil. Arq Bras Endocrinol Metabol 2007; 51: 437–42.CrossRefGoogle Scholar
  23. 23.
    Arantes HP, Kulak CA, Fernandes CE, et al. Correlation between 25–hydroxyvitamin D levels and latitude in Brazilian postmenopausal women: from the Arzoxifene Generations Trial. Osteoporos Int 2013; 24: 2707–12.CrossRefGoogle Scholar
  24. 24.
    Fitzpatrick TB. The validity and practicality of sun–reactive skin types I through VI. Arch Dermatol 1988; 124: 869–71.CrossRefGoogle Scholar
  25. 25.
    Eloi M, Horvath DV, Ortega JC, et al. 25–hydroxivitamin D serum concentration, not free and bioavailable vitamin D, is associated with disease activity in systemic lupus erythematosus patients. PLoS One 2017; 12: e0170323.Google Scholar
  26. 26.
    Holick MF, Binkley NC, Bischoff–Ferrari HA, et al. Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911–30.CrossRefGoogle Scholar
  27. 27.
    Mason RS, Reichrath J. Sunlight vitamin D and skin cancer. Anticancer Agents Med Chem 2013; 13: 83–97.CrossRefGoogle Scholar
  28. 28.
    Reichrath J, Saternus R, Vogt T. Challenge and perspective: the relevance of ultraviolet (UV) radiation and the vitamin D endocrine system (VDES) for psoriasis and other inflammatory skin diseases. Photochem Photobiol Sci 2017; 16: 433–44.CrossRefGoogle Scholar
  29. 29.
    Bikle DD, Vitamin DD. D receptor, a tumor suppressor in skin. Can J Physiol Pharmacol 2015; 93: 349–54.CrossRefGoogle Scholar
  30. 30.
    Mitschele T, Diesel B, Friedrich M, et al. Analysis of the vitamin D system in basal cell carcinomas (BCCs). Lab Invest 2004; 84: 693–702.CrossRefGoogle Scholar
  31. 31.
    Caini S, Boniol M, Tosti G, et al. Vitamin D and melanoma and non–melanoma skin cancer risk and prognosis: a comprehensive review and meta–analysis. Eur J Cancer 2014; 50: 2649–58.CrossRefGoogle Scholar
  32. 32.
    Kostner K, Denzer N, Koreng M, et al. Association of genetic variants of the vitamin D receptor (VDR) with cutaneous squamous cell carcinomas (SCC) and basal cell carcinomas (BCC): a pilot study in a German population. Anticancer Res 2012; 32: 327–33.Google Scholar
  33. 33.
    Reichrath J, Saternus R, Vogt T. Endocrine actions of vitamin D in skin: relevance for photocarcinogenesis of non–melanoma skin cancer, and beyond. Mol Cell Endocrinol 2017; 453: 96–102.CrossRefGoogle Scholar
  34. 34.
    Lopes JB, Fernandes GH, Takayama L, Figueiredo CP, Pereira RM. A predictive model of vitamin D insufficiency in older community people: from the Sao Paulo Aging & Health Study (SPAH). Maturitas 2014; 78: 335–40.CrossRefGoogle Scholar
  35. 35.
    Schalka S, Steiner D, Ravelli FN, et al. Brazilian consensus on photoprotection. An Bras Derm Sifilogr 2014; 89: 1–74.CrossRefGoogle Scholar
  36. 36.
    Liang G, Nan H, Qureshi AA, Han J. Pre–diagnostic plasma 25–hydroxyvitamin D levels and risk of non–melanoma skin cancer in women. PLoS One 2012; 7: e35211.CrossRefGoogle Scholar
  37. 37.
    Skaaby T, Husemoen LL, Thuesen BH, et al. Prospective population–based study of the association between serum 25–hydroxyvitamin–D levels and the incidence of specific types of cancer. Cancer Epidemiol Biomarkers Prev 2014; 23: 1220–9.CrossRefGoogle Scholar
  38. 38.
    Madan V, Lear JT, Szeimies RM. Non–melanoma skin cancer. Lancet 2010; 375: 673–85.CrossRefGoogle Scholar
  39. 39.
    Weishaar T, Rajan S, Keller B. Probability of vitamin D deficiency by body weight and race/ethnicity. J Am Board Fam Med 2016; 29: 226–32.CrossRefGoogle Scholar
  40. 40.
    Eide MJ, Johnson DA, Jacobsen GR, et al. Vitamin D and nonmelanoma skin cancer in a health maintenance organization cohort. Arch Dermatol 2011; 147: 1379–84.CrossRefGoogle Scholar
  41. 41.
    Tang JY, Parimi N, Wu A, et al. Inverse association between serum 25(OH) vitamin D levels and non–melanoma skin cancer in elderly men. Cancer Causes Control 2010; 21: 387–91.CrossRefGoogle Scholar
  42. 42.
    Cardoso F, Mesquita GV, Campelo V, et al. Prevalence of photoprotection and its associated factors in risk group for skin cancer in Teresina, Piaui. An Bras Derm Sifilogr 2017; 92: 206–10.CrossRefGoogle Scholar
  43. 43.
    Libon F, Courtois J, Le Goff C, et al J. Sunscreens block cutaneous vitamin D production with only a minimal effect on circulating 25–hydroxyvitamin D. Arch Osteoporos 2017; 12: 66.CrossRefGoogle Scholar
  44. 44.
    Marks R, Foley PA, Jolley D, Knight KR, Harrison J, Thompson SC. The effect of regular sunscreen use on vitamin D levels in an Australian population. Results of a randomized controlled trial. Arch Dermatol 1995; 131: 415–21.Google Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Andressa M. Soares
    • 1
  • Vera L. Szejnfeld
    • 1
  • Mauro Y. Enokihara
    • 2
  • Nílceo Michalany
    • 3
  • Charlles HM Castro
    • 1
    Email author
  1. 1.Rheumatology DivisionUniversidade Federal de São Paulo/Escola Paulista de Medicina (Unifesp/ EPM)São PauloBrazil
  2. 2.Department of DermatologyUniversidade Federal de São Paulo/Escola Paulista de Medicina (Unifesp/ EPM)São PauloBrazil
  3. 3.Department of PathologyUniversidade Federal de São Paulo/Escola Paulista de Medicina (Unifesp/ EPM)São PauloBrazil

Personalised recommendations